This suggests that the non-target metabolite m/z 363.0888 has immunomodulatory capabilities through FUT2 and thus has potential effects in Celiac, Crohn’s disease, and type 1 diabetes (Additional file 5: Fig. S7a). This evidence concerns the gene FUT2 and Crohn disease.